-
Create
account -
Build trading strategies
with no code -
Validate
& Backtest -
Connect exchange
& start earning
Quant Strategies & Backtesting results for DNLI
Here are some DNLI trading strategies along with their past performance. You can validate these strategies (and many more) for free on Vestinda across thousands of assets and many years of historical data.
Quant Trading Strategy: Random Walk Index Trend with Doji on DNLI
The backtesting results for the trading strategy from October 6, 2023, to November 6, 2023, indicate a profit factor of 0.13. However, the annualized return on investment shows a significant decline of -79.25%. The average holding time for trades was 19 hours and 6 minutes, with an average of 1.13 trades per week. The number of closed trades during this period was 5. The return on investment was recorded at -6.73%. Furthermore, the percentage of winning trades was only 40%. These statistics highlight a substantial loss in terms of the overall profitability of the strategy, suggesting a need for review and potential adjustments.
Quant Trading Strategy: Follow the trend on DNLI
Based on the backtesting results statistics for the trading strategy from November 6, 2022, to November 6, 2023, several key insights can be drawn. The profit factor of 0.77 indicates that the strategy's overall profitability was lower than its total losses. With an annualized ROI of -4.15%, the strategy yielded negative returns. The average holding time of 4 weeks and 4 days suggests a relatively long-term approach. The average trades per week were minimal, with only 0.07 trades executed weekly. The number of closed trades stood at 4, highlighting a conservative approach. With a winning trades percentage of 25%, the strategy displayed limited success. However, it outperformed the buy-and-hold strategy, generating excess returns of 23.15%. Overall, these results indicate a need for further refinement and optimization of the trading strategy.
Golden Cross Guide for Denali Therapeutics
- Identify the long-term moving average and the short-term moving average of DNLI.
- Wait for the short-term moving average to cross above the long-term moving average.
- Consider this crossover as a signal to buy DNLI stock.
- Confirm the golden cross with other technical indicators or price patterns.
- Place a stop-loss order to limit potential losses in case the trend reverses.
- Monitor the stock's performance and make necessary adjustments to the position.
The golden cross can indicate a bullish trend and help guide investment decisions.
Navigating Uncertainty: DNLI's Risk Management Strategies
Volatility and risk management play a crucial role in the world of investing. DNLI, like any other stock, is subject to market fluctuations. These fluctuations can lead to substantial gains or losses for investors. Therefore, understanding and managing volatility is of utmost importance. Effective risk management ensures that investors are prepared for unexpected fluctuations in the market. By diversifying their investment portfolio and setting stop-loss orders, investors can mitigate potential losses and protect their capital. Additionally, implementing a risk management strategy involves monitoring market trends, analyzing historical data, and staying informed about company-specific news. This proactive approach allows investors to make informed decisions and react appropriately to market volatility. Ultimately, by effectively managing volatility and risks, investors can maximize their potential returns while minimizing potential losses.
Denali Therapeutics: A Brief Company Profile
DNLI, also known as Denali Therapeutics, is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. With a mission to become a leader in the field, DNLI leverages its deep understanding of the biology of neurodegeneration to design targeted treatments. The company utilizes a diverse portfolio of technologies, including advanced antibody discovery platforms and small molecule expertise. DNLI aims to address unmet medical needs by targeting debilitating conditions like Alzheimer's and Parkinson's diseases. By harnessing the power of cutting-edge science and collaboration, DNLI strives to deliver transformative treatments and improve the lives of patients worldwide. With a dedication to making a difference, DNLI is driven by its commitment to innovation, scientific excellence, and patient-centricity.
Unlocking the Potential of Golden Cross Trading
The Golden Cross is a popular trading strategy used by technical analysts. It occurs when a short-term moving average crosses above a long-term moving average, signaling a bullish trend. This crossover is seen as a strong buy signal, indicating that a stock's price will continue to rise. Traders often use the 50-day and 200-day moving averages to identify a Golden Cross. When the shorter average moves above the longer average, it confirms a change in market sentiment. This strategy is widely followed by traders and investors as it can provide valuable insights into market trends. For instance, in the case of DNLI, if its 50-day moving average crosses above the 200-day moving average, it could indicate a potentially profitable trade.
Challenges in Interpreting DNLI's Golden Cross Signals
False Signals and Limitations of Golden Cross
While the Golden Cross is a widely followed technical indicator, it is not foolproof. False signals can occur when the moving averages cross, leading to incorrect predictions. DNLI, for example, experienced a false signal in June 2021, resulting in a misleading buy signal. Similarly, limitations exist due to the lagging nature of moving averages. Long-term traders may find the Golden Cross less useful as it may not provide timely signals for their trading strategies. Furthermore, the Golden Cross may not work well in highly volatile or sideways markets where price movements are erratic. Traders must exercise caution and not solely rely on the Golden Cross indicator but consider other indicators and factors to make well-informed trading decisions.
-
100,000 available assets New
-
years of historical data
-
practice without risking money
Frequently Asked Questions
To backtest a Golden Cross strategy for DNLI, follow these steps:
1. Retrieve historical price data for DNLI.
2. Identify the two moving averages; typically the 50-day and 200-day moving averages.
3. Determine the "Golden Cross" signal when the shorter moving average crosses above the longer one.
4. Execute a buy order when the signal occurs.
5. Monitor DNLI's performance until another signal is generated.
6. If the shorter moving average crosses below the longer one (a "Death Cross"), sell the position.
7. Repeat these steps, keeping track of profits and losses to evaluate the strategy's effectiveness.
To identify a Golden Cross failure and minimize losses in DNLI trading, closely monitor the price action and volume patterns after the Golden Cross occurs - which is when the short-term moving average crosses above the long-term moving average. If the stock fails to sustain upward momentum and starts to decline significantly with decreasing volume, it suggests a potential failure. It is important to set a stop-loss level to limit losses if the trade goes against your expectations. Additionally, regularly review and adjust your trading strategy based on market conditions and individual stock performance to minimize losses effectively.
To use the Golden Cross in conjunction with support and resistance levels for DNLI trading, first, identify the Golden Cross pattern when the shorter-term moving average (e.g., 50-day) crosses above the longer-term moving average (e.g., 200-day). This signals a potential bullish trend. Next, look for key support and resistance levels on DNLI's price chart. When the price approaches a support level, it may present a buying opportunity if the Golden Cross confirms the bullish trend. Similarly, near resistance levels, the Golden Cross could signal a potential sell opportunity. Always consider other technical indicators and fundamental analysis to confirm signals and manage risk.
A Golden Cross is a bullish signal often used in DNLI or any other trading to predict potential price increases. It occurs when the short-term moving average, like the 50-day moving average, crosses above the long-term moving average, such as the 200-day moving average. This crossover suggests that the recent upward momentum in the stock's price is likely to continue. Traders often interpret the Golden Cross as a buy signal, indicating a favorable time to enter or hold a long position in DNLI or any other security being analyzed. However, it's crucial to consider other factors and conduct further analysis before making investment decisions.
Conclusion
In conclusion, DNLI Golden Cross Trading is a valuable strategy for investors looking to identify potential buy signals in the stock market. By analyzing the EMA golden cross and the EMA 50 200 cross on DNLI Golden Cross Trading charts, investors can gain insights into bullish trends and make informed investment decisions. However, it is essential to understand the limitations and potential false signals that can occur with the Golden Cross indicator. By considering other technical indicators and market factors, investors can enhance their trading decisions and effectively manage volatility and risk. DNLI, as a biotechnology company focused on neurodegenerative diseases, offers opportunities for investors to capitalize on market trends while contributing to innovative therapies.